Related Experiment Videos
Microdeposits of amyloid in sclerocalcific heart valves: a histochemical and immunofluorescence study
Abstract:
Amyloid associated with seven sclerotic and two normal aortic and mitral valves was studied. The sclerotic valve amyloid contained microfibrils with typical random orientation and a fibril width of 9.5-12.5 nm. The amyloid deposits demonstrated permanganate-resistant Congophilia and contained the amino acid tryptophan. Immunofluorescence studies showed P-component in amyloid deposits of 6 of 7 valves, but none of the sclerotic valves contained amyloid fibril proteins of the AL (primary), AA (secondary), AEt (medullary thyroid carcinoma) or ASc1 (senile cardiac) types. Two non-sclerotic valves, removed from a patient with systemic amyloidosis, showed permanganate-sensitive Congophilic amyloid deposits which contained amyloid fibril protein AA.
Insights
Amyloid in sclerotic aortic and mitral valves contains P-component but not common amyloid types. Non-sclerotic valves from a systemic amyloidosis patient contained AA amyloid.
Area of Science:
- Cardiovascular Pathology
- Biochemistry
- Immunohistochemistry
Background:
- Amyloidosis is a group of diseases characterized by extracellular deposition of misfolded proteins.
- Cardiac involvement in amyloidosis can affect heart valves, leading to dysfunction.
- Understanding the specific types of amyloid deposited in cardiac valves is crucial for diagnosis and treatment.
Purpose of the Study:
- To characterize the amyloid deposits found in sclerotic aortic and mitral valves.
- To differentiate the amyloid types in sclerotic valves from those in non-sclerotic valves associated with systemic amyloidosis.
Main Methods:
- Analysis of amyloid microfibrils from sclerotic valves using electron microscopy.
- Assessment of amyloid staining properties (Congophilia) and amino acid composition.
- Immunofluorescence studies to detect specific amyloid fibril proteins (AL, AA, AEt, ASc1, P-component).
Main Results:
- Sclerotic valve amyloid showed microfibrils (9.5-12.5 nm), permanganate-resistant Congophilia, and contained tryptophan.
- P-component was detected in 6 of 7 sclerotic valves.
- No AL, AA, AEt, or ASc1 amyloid types were found in sclerotic valves.
- Non-sclerotic valves from a systemic amyloidosis patient contained AA amyloid.
Conclusions:
- Amyloid in sclerotic aortic and mitral valves is distinct from common systemic amyloidosis types, characterized by P-component.
- The findings suggest a unique pathway for amyloid deposition in degenerative valve disease.
- AA amyloid is associated with systemic amyloidosis affecting non-sclerotic valves.